Harrow Health Valuation
| HROWL Stock | USD 25.35 0.05 0.20% |
At this time, the firm appears to be fairly valued. Harrow Health 8625 retains a regular Real Value of $24.74 per share. The prevalent price of the firm is $25.35. Our model calculates the value of Harrow Health 8625 from evaluating the firm fundamentals such as Number Of Shares Shorted of 2.76 K, return on equity of 0.45, and Net Income of (24.41 M) as well as inspecting its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Harrow Health's price fluctuation is very steady at this time. Calculation of the real value of Harrow Health 8625 is based on 3 months time horizon. Increasing Harrow Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Harrow stock is determined by what a typical buyer is willing to pay for full or partial control of Harrow Health 8625. Since Harrow Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Harrow Stock. However, Harrow Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 25.35 | Real 24.74 | Hype 25.35 | Naive 25.45 |
The intrinsic value of Harrow Health's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Harrow Health's stock price.
Estimating the potential upside or downside of Harrow Health 8625 helps investors to forecast how Harrow stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Harrow Health more accurately as focusing exclusively on Harrow Health's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Harrow Health's intrinsic value based on its ongoing forecasts of Harrow Health's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Harrow Health's closest peers.
Harrow Health Cash |
|
Harrow Valuation Trend
Knowing Harrow Health's actual value is paramount for traders when making sound investment determinations. Using both Harrow Health's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Harrow Health Total Value Analysis
Harrow Health 8625 is currently anticipated to have takeover price of 0 with market capitalization of 247.48 M, debt of 190.5 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Harrow Health fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 247.48 M | 190.5 M |
Harrow Health Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Harrow suggests not a very effective usage of assets in November.Harrow Health Profitability Analysis
The company reported the revenue of 130.19 M. Net Loss for the year was (24.41 M) with profit before overhead, payroll, taxes, and interest of 0.Harrow Health Past Distributions to stockholders
About Harrow Health Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Harrow Health 8625. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Harrow Health 8625 based exclusively on its fundamental and basic technical indicators. By analyzing Harrow Health's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Harrow Health's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Harrow Health. We calculate exposure to Harrow Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Harrow Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 90.6 M | 95.1 M | |
| Pretax Profit Margin | (0.18) | (0.19) | |
| Net Loss | (0.19) | (0.20) | |
| Gross Profit Margin | 0.70 | 0.47 |
A single share of Harrow Health represents a small ownership stake in the entity. As a stockholder of Harrow, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Harrow Health Dividends Analysis For Valuation
Dividend Paid And Capex Coverage Ratio is expected to rise to 0.03 this year, although the value of Dividends Paid will most likely fall to about 749 K. . Retained Earnings is expected to rise to about (127.2 M) this year. The value of Retained Earnings Total Equity is expected to slide to about (103.5 M)
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 788.4 K | 749 K | |
| Dividend Payout Ratio | (0.01) | (0.01) | |
| Dividend Paid And Capex Coverage Ratio | 0.03 | 0.03 |
There are various types of dividends Harrow Health can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Harrow shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Harrow Health 8625 directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Harrow pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Harrow Health by the value of the dividends paid out.
Harrow Health Growth Indicators
Investing in growth stocks can be very risky. If the company such as Harrow Health does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 32.6 M |
Harrow Health Current Valuation Indicators
Harrow Health's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Harrow Health's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Harrow Health, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Harrow Health's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Harrow Health's worth.When determining whether Harrow Health 8625 is a strong investment it is important to analyze Harrow Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Harrow Health's future performance. For an informed investment choice regarding Harrow Stock, refer to the following important reports: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health 8625. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Equity 0.4484 |
The market value of Harrow Health 8625 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.